General Instructional ObjectiveGIO Specific Behavioral ObjectivesSBOs (1) (2)
(3) (4) (Standard Precautions ) (5) ( )
(6) (7) ( ) ( ) QOL(Quality of Life) ( ) (8) 1
2 (1) (2) (3) 4 24 (4) 3 ABC3
(common disease) up to datepub medbest evidence 20
common disease up to date pub med best evidence CDROM
A CTMRI MRI B
C
D QOL
1. () () () () () X CT () () () () () () () () () () () NIPPV () () () ()
() () () () () () () () () () () ()
() () () () ()
1. 2. 3.
SB EISEVL EMRESTEPD TAEPEIT PBC, PSS 4.
A 1 2 3 4 Na Na 5 K K 6 7 8 9 10 11 12 13 sick day 14 15 16 17 18IgA 19 20 21
22 23 24 25 26 27 28 29 30 B 1 2 3 4 5 6 7 8 9 10 11 12 CT,MRI 13 IC 14 6
1) 2) 3) 4) 5)
1 6 2 1) 1 30 2) 3) 1 2 3 4 4) 5) 6)
ABC3
() () () (DIC) PAIgG ()
() in situ hybridization(ish) () () CT MRI B (Hodgkin non-hodgkin ) graft-versus-host disease(gvhd) (AIDS)
B12 EPO, G-CSF Donor lymphocyte infusion(dli) plasmapheresis cytapheresis(leukapheresis) CD20
A Oncologic emergency
() () () SOAP () () () () () ()
()
1) 2) 3) 4) 5) 6) 7) 8) 9) 10) 11) 12) 13) 14) QOL
15) 16) 17) 18) 19) 20) (A) (B) (C) (A) (B) (B) (B) (A) (A) 12 (A) (B) (A)
(B) (A) (B) PCR (B) (A) (B) (B) (A) (C) (A) (C) (B) (B) CT (B) (C) MRI (C) (C) (C) 20) 21)
22) CPC (1) (2) (3) (4) (5) (6) (7)
(8) 1 (9) (10) 1 8 2 1 ABC3
X X CT MRI
70
3 A, B, C A B C 70
+ + +
()
() 4 ()
ABC3
(MMT) (ROM) (ADL) X scan (EMG) ( )
( ) () () ABC3
6
QOL () () Leopold Apgar ScoreSilverman score A B () A A
A B () A A () A () A A A () A A () B B B () B B CT A MRI A B () () 5 () () 5 ()
() () () () () () () () () () () CTMRI () () () () ()
() () 5 1 1 1
1) 2)
3) 4) 5) 6) 1 4 2 ABC3
KUBIVP CTMRI 57
63 7 4 ESWL 1) 2) 3) 4) 5)
ABC3
70
1. 2. 3. 4. 5. 1. 2. 3. 4. 5. 1. 2.
1. 2. 1. HBsAg HCV HIV1/2 TP 2. A RS 3. 1. 2. 3. 1. 2. 3.in situ hybridization 4. 5.
1 2 1 2 3 4 5 6 7 8 9 10) 1 4 2
4 1 3 104 12 18 6 24 8 6 4 4 4 96 4 1 1 2 2 2